UK Judge Nixes AbbVie Humira Patents In Biosimilars Case
A U.K. judge on Friday ruled that two European patents covering AbbVie's blockbuster arthritis drug Humira are invalid, in a victory for the biosimilars units of Samsung and Fujifilm, which are...To view the full article, register now.
Already a subscriber? Click here to view full article